Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury

8Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study was to investigate whether polymerized human placenta hemoglobin (PolyPHb) given before ischemia protects in vivo rat heart function against ischemia/reperfusion (I/R) injury. Forty-five male Sprague-Dawley rats were randomly divided (n = 15 per group) into a sham group, control group (pretreatment with Lactated Ringer's solution), or PolyPHb group (pretreatment with 0.1gHb/kg PolyPHb). Rat hearts were subjected to 30-min ischemia by occlusion of left anterior descending, followed by 2-hr reperfusion. As compared to the control group, PolyPHb preserved cardiac function and reduced cardiac troponin-I release and histopathological changes. Therefore, PolyPHb pretreatment provided a profound cardioprotective effect on the in vivo rat heart. © 2011 Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Li, T., Zhou, R., Xiang, X., Zhu, D., Li, Y., Liu, J., … Yang, C. (2011). Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury. Artificial Cells, Blood Substitutes, and Biotechnology, 39(6), 392–397. https://doi.org/10.3109/10731199.2011.611472

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free